Patent expiry of blockbuster drug opens door for Chinese drug makers to challenge multinationals in booming weight-loss ...
China's fast-growing market for GLP-1 weight-loss drugs is bracing for a major shake-up as the core compound patent for semaglutide was expiring in March, opening the door for multiple domestic ...
11dOpinion
Generic versions of weight-loss drugs are a bulky opportunity for Chinese and Indian drugmakers
The simultaneous patent expiry of Ozempic in China and India has seen generic makers jump in. Low cost production in high ...
April 1 (Reuters) - Eli Lilly on Wednesday became the second company to gain approval for a weight-loss pill, as the ...
The company has not disclosed pricing or a launch timeline. The approval also comes as Novo Nordisk's Wegovy nears patent expiry later this month, potentially paving the way for lower-cost copycat ...
China has granted approval for a Pfizer GLP-1 based medication for weight management, marking a significant milestone in the country’s rapidly expanding market for obesity and metabolic-health ...
China’s BrightGene has served up a slice of early-stage data to remind everyone it has a horse in the oral obesity race. | ...
A new, strange phenomenon called the “plastic eating” trend for weight loss is gaining momentum in China on TikTok. According to clips doing the rounds on the internet, people, especially youngsters, ...
When Wang Zhucen signed up for the first-ever weight management course at Dalian University of Technology in the northeastern ...
A Utah licensed Osteopathic Physician has been federally indicted after he allegedly received, recommended, and sold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results